Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

JOSEPH MEROLA

Allopathic & Osteopathic Physicians Dermatology

NPI
1881807469
CMS profile
175866
Location
DALLAS, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2020 · Entire year

$175,277.82

68 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

Other CMS categories — not shown on this page

Research Payments

CMS also publishes Research Payments as a separate dataset. This site does not currently mirror it, and no research figure is shown on this page. This provider appears in that dataset.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

These records are published by CMS and can be viewed on this provider’s official CMS record. View this provider on CMS Open Payments ↗

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2020 · entire year · sorted by reported total

By paying entity

PY2020 · entire year · sorted by reported total

Paying entityAmountRecords
Novartis Pharmaceuticals Corporation $34,283.78 15
LEO Pharma Inc. $19,920.00 4
UCB SA $17,200.00 2
Novartis Pharma AG $15,712.09 5
E.R. Squibb & Sons, L.L.C. $13,259.00 5
Amgen Inc. $12,637.42 7
Eli Lilly and Company $11,925.00 3
Janssen Global Services, LLC $11,680.00 3
ABBVIE INC. $9,011.12 7
GENZYME CORPORATION $8,028.00 1
Janssen Biotech, Inc. $7,401.49 4
LEO Pharma AS $5,468.04 2
UCB, Inc. $3,320.00 1
Gilead Sciences, Inc. $1,625.00 2
Biogen, Inc. $1,450.00 2
Janssen Scientific Affairs, LLC $1,300.00 2
SANOFI-AVENTIS U.S. LLC $731.88 2
EMD Serono, Inc. $325.00 1

Payment records · PY2020

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2020 · Physicians and non-physician practitioners · CMS publication 2026-06-30

68 matching records · $175,277.82 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 68 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–50 of 68.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
E.R. Squibb & Sons, L.L.C. $2,205.0012/28/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026727843543 CMS
Novartis Pharma AG $1,830.0012/17/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026729196513 CMS
Novartis Pharma AG $4,500.0012/15/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026729196191 CMS
UCB SA $6,000.0012/10/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026746118907 CMS
GENZYME CORPORATION $8,028.0012/04/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026744266069 CMS
LEO Pharma Inc. $4,980.0012/04/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026746683799 CMS
AbbVie Inc. $600.0012/03/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026722033163 CMS
E.R. Squibb & Sons, L.L.C. $4,000.0012/02/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026727843553 CMS
Amgen Inc. $2,031.3011/25/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026741153281 CMS
Amgen Inc. $2,200.0011/25/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026741404109 CMS
LEO Pharma AS $3,266.5511/25/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026746664951 CMS
UCB, Inc. $3,320.0011/24/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026746105813 CMS
Novartis Pharmaceuticals Corporation $4,680.0010/20/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026726020399 CMS
LEO Pharma Inc. $8,300.0010/16/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026746683797 CMS
Biogen, Inc. $725.0010/14/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026737266045 CMS
AbbVie Inc. $2,400.0010/07/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026722033161 CMS
EMD Serono, Inc. $325.0010/02/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026751288637 CMS
Janssen Biotech, Inc. $1,950.0009/29/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026719226691 CMS
Novartis Pharmaceuticals Corporation $3,600.0009/24/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026726020413 CMS
Novartis Pharmaceuticals Corporation $0.5009/24/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026726020425 CMS
Gilead Sciences, Inc. $1,300.0009/21/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026743816389 CMS
Eli Lilly and Company $5,600.0009/02/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026753918653 CMS
E.R. Squibb & Sons, L.L.C. $2,940.0008/27/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026727843517 CMS
Novartis Pharmaceuticals Corporation $3,600.0008/24/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026726020405 CMS
LEO Pharma Inc. $1,660.0008/14/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026746683793 CMS
Biogen, Inc. $725.0008/13/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026737266043 CMS
Novartis Pharmaceuticals Corporation $7,560.0008/07/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026726020431 CMS
AbbVie Inc. $600.0007/31/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026722033159 CMS
ABBVIE INC. $3,504.4507/24/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026932440621 CMS
ABBVIE INC. $406.6707/24/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026932440625 CMS
Amgen Inc. $3,504.4507/24/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026741153275 CMS
Amgen Inc. $406.6707/24/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026741153279 CMS
LEO Pharma AS $2,201.4907/24/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026746664947 CMS
Amgen Inc. $1,310.0007/20/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026741404105 CMS
Amgen Inc. $1,965.0007/20/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026741404107 CMS
LEO Pharma Inc. $4,980.0007/16/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026746683791 CMS
Janssen Global Services, LLC $5,200.0007/08/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026718911631 CMS
Janssen Biotech, Inc. $2,201.4907/07/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026719226693 CMS
Novartis Pharmaceuticals Corporation $720.0007/05/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026726020395 CMS
Janssen Biotech, Inc. $1,950.0006/25/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026719226689 CMS
Eli Lilly and Company $4,025.0006/17/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026753918159 CMS
Novartis Pharmaceuticals Corporation $2,160.0006/12/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026726020417 CMS
Eli Lilly and Company $2,300.0005/07/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026728500679 CMS
AbbVie Inc. $300.0004/27/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026722033157 CMS
Novartis Pharmaceuticals Corporation $2,880.0004/21/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026726020383 CMS
Novartis Pharmaceuticals Corporation $2,880.0004/18/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026753370657 CMS
UCB SA $11,200.0004/14/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026746118377 CMS
Janssen Biotech, Inc. $1,300.0004/13/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026719226687 CMS
Amgen Inc. $1,220.0004/09/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026741153271 CMS
Janssen Global Services, LLC $3,240.0003/19/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026718911615 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $174,109.23 265
PY2020 $175,277.82 68
PY2021 $162,133.83 74
PY2022 $169,332.69 150
PY2023 $181,413.58 171
PY2024 $142,887.72 228
PY2025 $157,372.26 155

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Cite this record.

Plain
JOSEPH MEROLA, NPI 1881807469. IndustryPayments, data edition 2026-07-26T04:22:22Z. https://industrypayments.org/provider/npi-1881807469.
APA 7
IndustryPayments. (2026). JOSEPH MEROLA, NPI 1881807469 (Data edition 2026-07-26T04:22:22Z) [Data set]. https://industrypayments.org/provider/npi-1881807469
Bluebook
JOSEPH MEROLA, NPI 1881807469, IndustryPayments (data edition 2026-07-26T04:22:22Z), https://industrypayments.org/provider/npi-1881807469.

Source: Centers for Medicare & Medicaid Services, Open Payments.